These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26085928)

  • 41. Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres.
    Liang D; Walker J; Schwendeman PS; Chandrashekar A; Ackermann R; Olsen KF; Beck-Broichsitter M; Schwendeman SP
    Drug Deliv Transl Res; 2024 Apr; ():. PubMed ID: 38643259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
    Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
    Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying.
    Shi NQ; Zhou J; Walker J; Li L; Hong JKY; Olsen KF; Tang J; Ackermann R; Wang Y; Qin B; Schwendeman A; Schwendeman SP
    J Control Release; 2020 May; 321():756-772. PubMed ID: 31935481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles.
    Fisher PD; Palomino P; Milbrandt TA; Hilt JZ; Puleo DA
    J Biomater Sci Polym Ed; 2014; 25(11):1174-93. PubMed ID: 24903524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight.
    Mylonaki I; Allémann E; Delie F; Jordan O
    J Control Release; 2018 Sep; 286():231-239. PubMed ID: 30071251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles.
    Lio D; Yeo D; Xu C
    Nanoscale Res Lett; 2016 Dec; 11(1):9. PubMed ID: 26745977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.
    Sharifi F; Otte A; Yoon G; Park K
    J Control Release; 2020 Sep; 325():347-358. PubMed ID: 32645336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts.
    Kosinski AM; Pothen JM; Panitch A; Sivasankar MP
    Ann Otol Rhinol Laryngol; 2015 Jul; 124(7):572-8. PubMed ID: 25667215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of monomer order on the hydrolysis of biodegradable poly(lactic-co-glycolic acid) repeating sequence copolymers.
    Li J; Rothstein SN; Little SR; Edenborn HM; Meyer TY
    J Am Chem Soc; 2012 Oct; 134(39):16352-9. PubMed ID: 22950719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of protein delivery from modular polymer scaffolds.
    Lee M; Chen TT; Iruela-Arispe ML; Wu BM; Dunn JC
    Biomaterials; 2007 Apr; 28(10):1862-70. PubMed ID: 17184836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release.
    Nippe S; General S
    Eur J Pharm Sci; 2012 Nov; 47(4):790-800. PubMed ID: 22940138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery.
    Tinsley-Bown AM; Fretwell R; Dowsett AB; Davis SL; Farrar GH
    J Control Release; 2000 May; 66(2-3):229-41. PubMed ID: 10742583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Red blood cell membrane-camouflaged poly(lactic-co-glycolic acid) microparticles as a potential controlled release drug delivery system for local stellate ganglion microinjection.
    Liu B; Zhang D; Tu H; Alimi OA; Kong Y; Satyanarayana R; Kuss M; Li Y; Duan B
    Acta Biomater; 2023 Apr; 161():201-212. PubMed ID: 36858164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A synthetic polymer matrix for the delayed or pulsatile release of water-soluble peptides.
    Schachter DM; Kohn J
    J Control Release; 2002 Jan; 78(1-3):143-53. PubMed ID: 11772456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres.
    Doty AC; Weinstein DG; Hirota K; Olsen KF; Ackermann R; Wang Y; Choi S; Schwendeman SP
    J Control Release; 2017 Jun; 256():19-25. PubMed ID: 28342981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint.
    Mountziaris PM; Sing DC; Chew SA; Tzouanas SN; Lehman ED; Kasper FK; Mikos AG
    Pharm Res; 2011 Jun; 28(6):1370-84. PubMed ID: 21184147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended release peptide delivery systems through the use of PLGA microsphere combinations.
    Burton KW; Shameem M; Thanoo BC; DeLuca PP
    J Biomater Sci Polym Ed; 2000; 11(7):715-29. PubMed ID: 11011769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relating polymeric microparticle formulation to prevalence or distribution of fibronectin and poly-d-lysine to support mesenchymal stem cell growth.
    Ugur D; Sottile V; Montero-Menei CN; Boury F; Zelzer M
    Biointerphases; 2020 Aug; 15(4):041008. PubMed ID: 32752604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.